These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26293619)

  • 1. Immunoscoring by correlating MHC class II and TCR expression: high level immune functions represented by the KIRP dataset of TCGA.
    Butler SN; Blanck G
    Cell Tissue Res; 2016 Feb; 363(2):491-6. PubMed ID: 26293619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma.
    Ibrahim EC; Guerra N; Lacombe MJ; Angevin E; Chouaib S; Carosella ED; Caignard A; Paul P
    Cancer Res; 2001 Sep; 61(18):6838-45. PubMed ID: 11559559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Productively Rearranged TcR-α V-J Sequences in TCGA Exome Files: Implications for Tumor Immunoscoring and Recovery of Antitumor T-cells.
    Gill TR; Samy MD; Butler SN; Mauro JA; Sexton WJ; Blanck G
    Cancer Inform; 2016; 15():23-8. PubMed ID: 26966347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.
    Bukur J; Rebmann V; Grosse-Wilde H; Luboldt H; Ruebben H; Drexler I; Sutter G; Huber C; Seliger B
    Cancer Res; 2003 Jul; 63(14):4107-11. PubMed ID: 12874014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of HLA class II antigen-associated invariant chain on renal cell cancer].
    Saito T; Tomita Y; Kimura M; Nishiyama T; Sato S
    Nihon Hinyokika Gakkai Zasshi; 1993 Jun; 84(6):1036-40. PubMed ID: 8345720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes.
    Ogasawara M; Rosenberg SA
    Cancer Res; 1993 Aug; 53(15):3561-8. PubMed ID: 8101762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Major histocompatibility complex class II antigens on renal cell cancer--immunohistochemical study and effect on their expression by interferon].
    Tomita Y
    Nihon Hinyokika Gakkai Zasshi; 1990 Jul; 81(7):1079-86. PubMed ID: 2120500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of immune-related risk signature for renal papillary cell carcinoma.
    Wang Z; Song Q; Yang Z; Chen J; Shang J; Ju W
    Cancer Med; 2019 Jan; 8(1):289-304. PubMed ID: 30516029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of MHC antigen expression and tumor-infiltrating mononuclear cells in renal cell adenomas and carcinomas.
    Ohmori T; Okada K; Arita N; Watanabe Y; Miyazaki T; Tabei R
    Histol Histopathol; 1995 Oct; 10(4):789-94. PubMed ID: 8573998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of the expression of major histocompatibility complex class II antigen, HLA-DR and -DQ, with recurrence of papillary thyroid cancer.
    Jo YS; Lee JC; Li S; Choi YS; Bai YS; Kim YJ; Lee IS; Rha SY; Ro HK; Kim JM; Shong M
    Int J Cancer; 2008 Feb; 122(4):785-90. PubMed ID: 17957790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
    Walter W; Lingnau K; Schmitt E; Loos M; Maeurer MJ
    Br J Cancer; 2000 Nov; 83(9):1192-201. PubMed ID: 11027433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma.
    Gastl G; Ebert T; Finstad CL; Sheinfeld J; Gomahr A; Aulitzky W; Bander NH
    J Urol; 1996 Jan; 155(1):361-7. PubMed ID: 7490887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
    Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
    Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. γ-Interferon-regulated chaperone governs human lymphocyte antigen class II expression.
    Kämper N; Franken S; Temme S; Koch S; Bieber T; Koch N
    FASEB J; 2012 Jan; 26(1):104-16. PubMed ID: 21940994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoantigen Load, Antigen Presentation Machinery, and Immune Signatures Determine Prognosis in Clear Cell Renal Cell Carcinoma.
    Matsushita H; Sato Y; Karasaki T; Nakagawa T; Kume H; Ogawa S; Homma Y; Kakimi K
    Cancer Immunol Res; 2016 May; 4(5):463-71. PubMed ID: 26980598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis.
    Waldburger JM; Palmer G; Seemayer C; Lamacchia C; Finckh A; Christofilopoulos P; Baeten D; Reith W; Gabay C
    Arthritis Rheum; 2011 Nov; 63(11):3354-63. PubMed ID: 21739421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy.
    Leisegang M; Turqueti-Neves A; Engels B; Blankenstein T; Schendel DJ; Uckert W; Noessner E
    Clin Cancer Res; 2010 Apr; 16(8):2333-43. PubMed ID: 20371691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
    Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
    Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TcR-α recombinations in renal cell carcinoma exome files correlate with an intermediate level of T-cell exhaustion biomarkers.
    Mai AT; Tong WL; Tu YN; Blanck G
    Int Immunol; 2018 Feb; 30(1):35-40. PubMed ID: 29361059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human renal cell carcinoma antigen-specific CTLs: antigen-driven selection and long-term persistence in vivo.
    Jantzer P; Schendel DJ
    Cancer Res; 1998 Jul; 58(14):3078-86. PubMed ID: 9679974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.